Association between oocyte donors' or recipients' BMI with clinical outcomes after first single blastocyst transfers. The uterus is the mostly affected.

BMI miscarriage obesity oocyte donation overweight

Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
05 Aug 2023
Historique:
received: 28 02 2023
revised: 26 07 2023
accepted: 28 07 2023
medline: 8 8 2023
pubmed: 8 8 2023
entrez: 7 8 2023
Statut: aheadofprint

Résumé

To assess if high BMI in either oocyte donors or recipients is associated with poorer outcomes after first single blastocyst transfers. Retrospective study including 1394 first blastocyst single embryo transfers (SETs) conducted by 1394 recipients during oocyte donation cycles with the gametes retrieved from 1394 women (Jan2019-July2021). Four BMI clusters were defined for both donors and recipients (underweight: <18.5; normal weight: 18.5-24.9; over-weight: 25-29.9; obese: ≥30). 1394 recipients, 42.4±4.0 years old and with a BMI 23.2±3.8, and 1394 donors, 26.1±4.2 years old and with a BMI 21.9±2.5. All oocytes were vitrified at two egg banks and warmed at eight IVF clinics part of the same network. ICSI, blastocyst culture and either fresh or vitrified-warmed SETs were conducted. Putative confounders were investigated, and the data adjusted through regression analyses. The primary outcome was the live birth rate (LBR) per SET according to donors' and/or recipients' BMI. The main secondary outcome was the miscarriage rate (<22 The LBR per blastocyst SET showed no significant association with donors' BMI. Regarding recipients' BMI, instead, the multivariate-OR was significant in obese versus normal weight recipients (0.58, 95%CI 0.37-0.91, p=0.019). The miscarriage rate per clinical pregnancy was also significantly associated with recipients' obesity with a multivariate-OR of 2.31 (95%CI 1.18-4.51, p=0.014) versus normal weight patients. A Generalized Additive Model (GAM) method was used to represent the relationship between predicted LBR or miscarriage rates with donors' or recipients' BMI; it pictured a scenario where the former outcome moderately but continuously decreases with increasing recipients' BMI to then sharply decline in the BMI range 25-35. The miscarriage rate, instead, increases almost linearly with respect to both donors' and recipients' increasing BMI. Obesity mostly effects the uterus, especially due to higher miscarriage rates. Yet, poorer outcomes can be appreciated already with a BMI of 25 in both oocyte donors and recipients. Finer markers of nutritional homeostasis are therefore desirable, recipients should be counselled about poorer expected outcomes in case of overweight/obesity, and oocyte banks should avoid assigning oocytes from overweight donors to overweight/obese recipients.

Identifiants

pubmed: 37549838
pii: S0015-0282(23)00725-2
doi: 10.1016/j.fertnstert.2023.07.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Gemma Fabozzi (G)

IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy; IVIRMA Global Research Alliance, B-WOMAN, Rome, Italy; Department of Biomedicine and Prevention, University of Rome, Tor Vergata, Rome, Italy. Electronic address: fabozzi@generapma.it.

Danilo Cimadomo (D)

IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy. Electronic address: cimadomo@generapma.it.

Roberta Maggiulli (R)

IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy.

Alberto Vaiarelli (A)

IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy.

Vicente Badajoz (V)

IVIRMA Global Research Alliance, GINEFIV, Madrid, Spain.

Monica Aura (M)

IVIRMA Global Research Alliance, GINEFIV, Barcelona, Spain.

Stefano Canosa (S)

IVIRMA Global Research Alliance, LIVET, Turin, Italy.

Francesca Bongioanni (F)

IVIRMA Global Research Alliance, LIVET, Turin, Italy.

Francesca Benini (F)

IVIRMA Global Research Alliance, DEMETRA, Florence, Italy.

Claudia Livi (C)

IVIRMA Global Research Alliance, DEMETRA, Florence, Italy.

Carlotta Zacà (C)

IVIRMA Global Research Alliance, 9.baby, Bologna, Italy.

Andrea Borini (A)

IVIRMA Global Research Alliance, 9.baby, Bologna, Italy.

Erminia Alviggi (E)

IVIRMA Global Research Alliance, GENERA, Clinica Ruesch, Naples, Italy.

Benedetta Iussig (B)

IVIRMA Global Research Alliance, GENERA, GENERA Veneto, Marostica, Italy.

Maria Hebles (M)

IVIRMA Global Research Alliance, GINEMED, Sevilla, Spain.

Pascual Sànchez (P)

IVIRMA Global Research Alliance, GINEMED, Sevilla, Spain.

Valentino Cimadomo (V)

Bank of New York Mellon, Wroclaw, Poland.

Laura Rienzi (L)

IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.

Joaquìn Llàcer (J)

IVIRMA Global Research Alliance, GINEFIV, Madrid, Spain.

Classifications MeSH